ArticleCancer2019

Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.

Celestia S Higano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.